ShareJunction - Stock Forum Messages %%%:

Back

First < Newer 2901-2920 of 10899 Older> Last

Latest Forum Topics / Biosensors

Post Reply

Is Biosensors a good buy?

topdog22
Senior

16-Sep-2011 23:20

topdog22 About Contact Quote this Post!

x 0
x 0

Alert Admin

Anyone know why BIG is buying Treasure Solutions Ltd???

Who are the shareholders of Treasure Solutions Ltd???

BIG did NOT announce anything about this acquisition except for the notice of meeting.

Useful To Me Not Useful To Me

alexchia01
Elite

04-Sep-2011 21:56

alexchia01 About Contact Quote this Post! Style: Combined Mood:

Yells: "Catch The Stars And Ride With Them"

x 0
x 0

Alert Admin

I already sold my Biosensors last Friday.

bishan22 ( Date: 04-Sep-2011 21:49) Posted:

Hope to join at 1.20-1.25 tomorrow. Smiley

alexchia01 ( Date: 31-Aug-2011 15:59) Posted:

Buy Biosensors again today.

Hopefully, this time can break higher.

Stop-Loss at $1.260.

Immediate Resistance at $1.330.

T.P. is $1.40.

Useful To Me Not Useful To Me

bishan22
Elite

04-Sep-2011 21:49

bishan22 About Contact Quote this Post!

x 0
x 0

Alert Admin

Hope to join at 1.20-1.25 tomorrow. Smiley

alexchia01 ( Date: 31-Aug-2011 15:59) Posted:

Buy Biosensors again today.

Hopefully, this time can break higher.

Stop-Loss at $1.260.

Immediate Resistance at $1.330.

T.P. is $1.40.

Useful To Me Not Useful To Me

lowchia
Veteran

04-Sep-2011 21:40

lowchia About Contact Quote this Post! Style: Technical Mood:

x 0
x 0

Alert Admin

On Friday, Biosensors re-test the resistance at $1.33 and closed at $1.315 with LOW volume of 1.82 million shares traded.

A black candle sticks with long lower shadow similar to “Hanging man” affirms on the weakness of the rally and pullback will be expected.

RSI & MACD are bullish as RSI trend upwards.

Important Resistance of Biosensors: $1.33

Immediate Support of Biosensors: $1.25

Currently prices are supported by 20/50/100 days MA.

Prices have consolidating .................. READ MORE

Useful To Me Not Useful To Me

alexchia01
Elite

31-Aug-2011 15:59

alexchia01 About Contact Quote this Post! Style: Combined Mood:

Yells: "Catch The Stars And Ride With Them"

x 0
x 0

Alert Admin

Buy Biosensors again today.

Hopefully, this time can break higher.

Stop-Loss at $1.260.

Immediate Resistance at $1.330.

T.P. is $1.40.

Useful To Me Not Useful To Me

swissvic
Member

31-Aug-2011 15:57

swissvic About Contact Quote this Post!

x 0
x 0

Alert Admin

Biosensors manufactures medical devices, producing drug-eluting stents used to widen narrowing arteries, critical care catheter systems, and blood pressure transducers.

Our Equities Team has picked out this stock to be a Growth Gem. We define a growth Gem as follows:

1. Strong growth in Sales relative to its industry for the past 5 years (13% CAGR* for Biosensors)
Significance: Receiving increasing business from customers

2. Strong growth in Earnings from Operations relative to its industry for the past 5 years. (9% CAGR for Biosensors)
Significance: Recurring earnings from core business is increasing

3. Strong growth in Profit Margin relative to its industry for the past 5 years. (53% CAGR for Biosensors)
Significance: Operations are improving even as sales increase, expenses decrease

4. Strong growth in Free Cash Flow relative to its industry for the past 5 years. (40% CAGR for Biosensors)
Significance: The amount of free cash to pursue future growth opportunities is increasing

5. Total number of Analyst Coverage is less than median of its industry.
Significance: The less analyst coverage, the less people know about it – undiscovered gem

*CAGR = Compounded Annual Growth Rate

Biosensors meets all the above conditions. What about technical analysis? Let’s take a look at today’s chart.

View Full-Sized Image
Bio Sensors Daily Chart with Fibonacci Retracement
Biosensors Daily Chart With Fibonacci Retracement

Not too bad. Biosensors enjoyed a 47% run up in the early half of this year, and has been consolidating ever since. This Growth Gem has weathered the recent downturn pretty well, supported by the 50% retracement level.

Glenn Ho is Director at AsiaPacFinance, serving retail investors globally through Research, Trading Strategies, and Investment Seminars. The financial portal collaborates with banks and brokerages by providing technical analysis and investor education across asset classes. AsiaPacFinance is also the first company to invent a stock screener that combines both fundamental and technical analysis. You can reach Glenn at AsiaPacFinance.

Useful To Me Not Useful To Me

alexchia01
Elite

15-Aug-2011 12:31

alexchia01 About Contact Quote this Post! Style: Combined Mood:

Yells: "Catch The Stars And Ride With Them"

x 0
x 0

Alert Admin

Buy Biosensors.

Kind of like what I see.

Stop-Loss at $1.245.

T.P. is $1.365.

Useful To Me Not Useful To Me

lowchia
Veteran

14-Aug-2011 21:29

lowchia About Contact Quote this Post! Style: Technical Mood:

x 0
x 0

Alert Admin

On Friday, Biosensors re-test the support at $1.25 and closed at $1.26 with LOW volume of 6.048 million shares traded.

A black candle sticks with long upper indicates prices attempt to rebound on the support of $1.25 but failed to close higher.

RSI & MACD are turning bullish as RSI perform a up tick on Friday.

Important Resistance of Biosensors: $1.34

Immediate Support of Biosensors: $1.25

Currently prices are resisted by 20/50/100 days MA.

Prices have............. READ MORE

Useful To Me Not Useful To Me

tiptop123
Member

14-Aug-2011 11:59

tiptop123 About Contact Quote this Post!

x 0
x 0

Alert Admin

Fund sold ~0.75M shares @1.235-1.28/share. Panic? Redemption? Fat Finger? Buy High-Sell Low Strategy? Smiley

After all fund managers are also human!!!

10-08-2011

1.	Holdings of Substantial Shareholder , including direct and deemed interest :

	Direct	Deemed
No. of shares held before the change	0	121,238,000
As a percentage of issued share capital	0 %	9.01 %
No. of shares held after the change	0	120,833,000
As a percentage of issued share capital	0 %	8.98 %

tiptop123 ( Date: 04-Aug-2011 20:44) Posted:

Bought another ~13.4M shares @ $1.24-1.38/share in 6 weeks. Smiley

29-07-2011

1.	Holdings of Substantial Shareholder , including direct and deemed interest :

	Direct	Deemed
No. of shares held before the change	0	120,250,000
As a percentage of issued share capital	0 %	8.94 %
No. of shares held after the change	0	121,590,000
As a percentage of issued share capital	0 %	9.04 %

tiptop123 ( Date: 19-Jun-2011 11:26) Posted:

Wow! They bought another ~13.3M shares @ $1.22-1.29/share in 2 weeks.

15-06-2011

1.	Holdings of Substantial Shareholder , including direct and deemed interest :

	Direct	Deemed
No. of shares held before the change	0	107,007,000
As a percentage of issued share capital	0 %	7.97% %
No. of shares held after the change	0	108,107,000
As a percentage of issued share capital	0 %	8.05 %

Useful To Me Not Useful To Me

tiptop123
Member

04-Aug-2011 20:44

tiptop123 About Contact Quote this Post!

x 0
x 0

Alert Admin

Bought another ~13.4M shares @ $1.24-1.38/share in 6 weeks. Smiley

29-07-2011

1.	Holdings of Substantial Shareholder , including direct and deemed interest :

	Direct	Deemed
No. of shares held before the change	0	120,250,000
As a percentage of issued share capital	0 %	8.94 %
No. of shares held after the change	0	121,590,000
As a percentage of issued share capital	0 %	9.04 %

tiptop123 ( Date: 19-Jun-2011 11:26) Posted:

Wow! They bought another ~13.3M shares @ $1.22-1.29/share in 2 weeks.

15-06-2011

1.	Holdings of Substantial Shareholder , including direct and deemed interest :

	Direct	Deemed
No. of shares held before the change	0	107,007,000
As a percentage of issued share capital	0 %	7.97% %
No. of shares held after the change	0	108,107,000
As a percentage of issued share capital	0 %	8.05 %

tiptop123 ( Date: 03-Jun-2011 23:51) Posted:

They have bought ~13.7M shares since 27 April 11, for $1.28-1.40 a share. Why are they so confident? Do they know something that we don't?

30-05-2011

1.	Holdings of Substantial Shareholder , including direct and deemed interest :

	Direct	Deemed
No. of shares held before the change	0	93,520,000
As a percentage of issued share capital	0 %	6.97 %
No. of shares held after the change	0	94,764,000
As a percentage of issued share capital	0 %	7.06 %

27-04-2011

1.	Holdings of Substantial Shareholder , including direct and deemed interest :

	Direct	Deemed
No. of shares held before the change	0	76,751,000
As a percentage of issued share capital	0 %	5.74 %
No. of shares held after the change	0	81,045,000
As a percentage of issued share capital	0 %	6.06 %

Useful To Me Not Useful To Me

allright
Senior

04-Aug-2011 09:09

allright About Contact Quote this Post!

x 0
x 0

Alert Admin

Sorry, it was 29th of July 2011 that FMR LLC bought 1.34 mln BIOSENSORS shares, raising holding to 121.59 mln shares

allright ( Date: 04-Aug-2011 09:07) Posted:

On the 27th of July 2011, FMR LLC bought 1.34 mln BIOSENSORS shares, raising holding to 121.59 mln shares

investor ( Date: 03-Aug-2011 22:31) Posted:

Biosensors hit an intra day low of 1.30, corresponding to its 50 day mva, closing at the day's high.

Technically, the stock looks remarkably resilient. Resistance at recent high of 1.39, does not look very formidable. If cleared, the 1.41 high should be within reach, and possibly breached as well.

On the downside, if the recent low of 1.26 were to be violated, with high volume, it may signal the beginning of a more serious correction.

Also, a point to note - in the recent Qtrly conference, 3 new analysts were present, ie Deutche Bank, Morgan Stanley, and our old friend Credit Suizze.

A possble catalyst for the stock to clear resistance would be an 'initial coverage' by any one of these new analysts.

Not a call to buy/sell.

Useful To Me Not Useful To Me

allright
Senior

04-Aug-2011 09:07

allright About Contact Quote this Post!

x 0
x 0

Alert Admin

On the 27th of July 2011, FMR LLC bought 1.34 mln BIOSENSORS shares, raising holding to 121.59 mln shares

investor ( Date: 03-Aug-2011 22:31) Posted:

Useful To Me Not Useful To Me

investor
Senior

03-Aug-2011 22:31

investor About Contact Quote this Post!

x 0
x 0

Alert Admin

Useful To Me Not Useful To Me

enghou
Senior

03-Aug-2011 01:35

enghou About Contact Quote this Post! Style: Combined Mood:

x 0
x 0

Alert Admin

Details of Normura's recommendation

Action: Raising TP following strong 1Q FY12 results
We raise our target price to SGD1.76 (from SGD1.59) and our earnings
estimates by 7-23% over our forecast period to reflect strong 1Q FY12
results. A key reason for the earnings lift is the strong market share gains
in Japan and continued progress in Biomatrix sales globally. We reiterate
our BUY rating for the stock.
Catalyst: Further gains in Japan, pending approvals
Japan will be a key earnings driver for Biosensors as Terumo achieves
higher market share there. The strong momentum in the 1Q results also
shows that Biomatrix is gaining acceptance globally. Other catalysts that
could further rerate the stock include CE mark approval for BioFreedom,
SFDA approval in China and strong clinical trial data for BioFreedom when
new data is released at the end of this year.
Valuation: Trading below our SOTP-derived TP of SGD1.76
Biosensors is trading below our sum-of-the-parts derived TP of SGD1.76.
Current valuation of 16x FY12F P/E and 12xFY13F P/E is undemanding,
in our view, given its strong growth prospects and enhanced balance
sheet. We expect the group to embark on M& A to further strengthen its
position in the DES space and other product adjacencies.

Good Luck

Useful To Me Not Useful To Me

investor
Senior

02-Aug-2011 11:56

investor About Contact Quote this Post!

x 0
x 0

Alert Admin

Nomura has upped Biosensors' target price to 1.76. Report dated 01st Aug 2011.

For Info.

Useful To Me Not Useful To Me

tbt001
Member

01-Aug-2011 12:18

tbt001 About Contact Quote this Post! Style: Fundamental

x 0
x 0

Alert Admin

According to Terumo's presentation, Nobori was launched on 5th May 2011 so the licence contribution is for nearly 2 months. Further when a new product launches there is always some demand from " stocking up" so it is hard to tell now how much of the incremental $10m in the 1QJun11 Qtr would be continuing sales for future quarters - could be more or could be less. I would wait for at least 6 more months before making an assessment.

I find that the 30% market share reported by Terumo very encouraging. This should grow in future years because it is the only Japanese made DES. My guess is 50% to 60% would be achievable.

As for the licensing percentage, the Biosensors declined to reveal the exact number. If you look at the Terumo presentation for FYE Mar2012, they sold about 6 bil yen, roughly US$75m. Taking Biosensor's licensing revenue of US$17.2m and dividing, we get about 23%. However we must bear in mind Biosensors also receive licensing income from other companies (albeit not very much).

Useful To Me Not Useful To Me

alexchia01
Elite

01-Aug-2011 11:46

alexchia01 About Contact Quote this Post! Style: Combined Mood:

Yells: "Catch The Stars And Ride With Them"

x 0
x 0

Alert Admin

I love Biosensors.

Currently, my Best performing counter.

May hit a resistance at $1.40, but it's ok.

I believe it would break through quite easily.

Useful To Me Not Useful To Me

investor
Senior

31-Jul-2011 18:51

investor About Contact Quote this Post!

x 0
x 0

Alert Admin

For those who are wondering just how much percentage of the revenue, that Terumo is paying to Biosensors for their sale in Europe, well, some info released by Terumo themselves, has help to clear the air.

Terumo stated that since the launch of the Nobori, they have accumulated revenue of 10 billion yen (as at end mar 2011) , or approx US$125m, taking 80 yen as 1 US$.

IF you accumulate the licensing fees that Biosensors has earned in end Mar 2009, end mar 2010, and end mar 2011, the fees are US$5m, US$9.09m and US$17.17m respectively, totalling US$31.26m.

Taking US$31.26m divided by US$125m, the percentage of revenue paid by Terumo to Biosensors, is 25 %!. (Plus or minus a few points due to FX rate, etc)

Now, we all know that Terumo negotiated with Biosensors, in 2008, and paid US$40m upfront, so as to lower the % of revenue paid, but the licensing agreement for Japan's sales was NOT negotiated, meaning that the percentage of revenue from Japan is HIGHER than 25 % !.

Now that is definitely, a plus for Biosensors.

Again, just some conjecture. Not a call to buy/sell.

Useful To Me Not Useful To Me

investor
Senior

29-Jul-2011 22:27

investor About Contact Quote this Post!

x 0
x 0

Alert Admin

Just went to Terumo's website to see their results' presentation.

Nobori was launched on 5th May 2011. According to the presentation, Nobori achieved a mkt share of 30 % in the mth of June !.

ALso, Terumo has forecast that total sales of Nobori for yr ending mar 2012 will be 20 billion yen, ie taking 80 yen to 1 US dollar, the forecast sale will be approx US$250m !.

Assuming that Nobori's royalty contribution to Biosensors in Europe for Q1 (ie end Jun 2011) is approx US$5m, that means that Nobori's royalty from Japan's sales is approx US$10m, and that is only for 1 and 1/2 mths of the qtr !

If sales remain the same, then the royalty contribution from Japan's sales for the next 3 qtrs will be US$20m per qtr, adding upto US$60m in royalties from Japan alone for the next 3 qtrs.

THat is, royalties from Terumo for the whole yr to Biosensors will total US$15m (Q1) + US$60m (from Japan for the next 3 qtrs), + US$15m (from Europe for the next 3 qtrs), giving a total contribution of US$95m. (before tax)

I don't know whether my maths is right or not, but OCBC's forecast for net profit for Biosensor's full yr ending Mar 2012 is only US$93m, which looks very, very conservative, when the contribution alone from Terumo is that much. (assumed )

My simplistic view may not be correct. Not a call to buy/sell.

Useful To Me Not Useful To Me

rogeryap
Member

29-Jul-2011 14:19

rogeryap About Contact Quote this Post!

x 0
x 0

Alert Admin

same old tactic!!

if they do the same as yesterday, shd close @ 1.38!!

Useful To Me Not Useful To Me

First < Newer 2901-2920 of 10899 Older> Last

ShareJunction Version: 27 Nov 2020 ver- All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright © SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux. Hosted with Signetique Cloud.